A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing

Background The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to 101739 confirmed cases, in Italy, as of March 30th, 2020. While the analogous event in China appears to be under control at the moment, the outbreaks in western countries are still at an early stage of development. Italy, at present, is playing a major role in understanding the transmission dynamics of these new infections and evaluating the effectiveness of control measures in a western social context.Methods We combined a quarantined model with early-stage development data in Italy (during the period February 20th - March 30th) to predict longer-term progression (up to March 30th, and till June 25th, 2020 in a longterm view) with different control measures. Due to significant variations in the control strategies, which have been changing over time, and thanks to the introduction of detection technologies leading to faster confirmation of the SARS-CoV-2 infections, we made use of time-dependent contact and diagnosis rates to estimate when the effective daily reproduction ratio can fall below 1. Within the same framework, we analyze the possible secondary infection event after relaxing the isolation measures.Outcomes and interpretation We study two simplified scenarios compatible with the observation data and the effects of two stringent measures on the evolution of the epidemic. On one side, the contact rate must be kept as low as possible, but it is also clear that, in a modern developed country, it cannot fall under certain minimum levels and for a long time. The complementary parameter tuned is the transition rate of the symptomatic infected individuals to the quarantined class, a parameter δI connected with the time tI = 1/δI needed to perform diagnostic tests. Within the conditions of the outbreak in Italy, this time must fall under 12-8 hours in order to make the reproduction number less than 1 to minimize the case numbers. Moreover, we show how the same parameter plays an even more important role in mitigating the effects of a possible secondary infection event.Funding No funding has been provided by private or public actors beyond the current clinical practice (National Health Service)..

Medienart:

Preprint

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

bioRxiv.org - (2021) vom: 24. März Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

Traini, Marco Claudio [VerfasserIn]
Caponi, Carla [VerfasserIn]
Ferrari, Riccardo [VerfasserIn]
De Socio, Giuseppe Vittorio [VerfasserIn]

Links:

Volltext [lizenzpflichtig]
Volltext [kostenfrei]

doi:

10.1101/2020.04.06.20055392

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XBI014894556